Tenax Therapeutics, Inc. (TENX)
USD 5.52
(-4.99%)
USD 5.52
(-4.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.9 Million | -12.01 Million | -10.85 Million | -9.27 Million | -7.55 Million | -5.49 Million |
| Net Income | -7.71 Million | -11.04 Million | -32.47 Million | -9.85 Million | -8.39 Million | -14.14 Million |
| Depreciation & Amortization | 7570.00 | 113.33 Thousand | 108.98 Thousand | 114.74 Thousand | 107.27 Thousand | 9016.00 |
| Deferred income taxes | -190.85 | -365.31 | -773.79 | -352.65 | -271.22 | 407.77 Thousand |
| Stock-based compensation | 190.85 | 365.31 | 773.79 | 352.65 | 271.22 | 190.08 Thousand |
| Change in working capital | 1.58 Million | -1.44 Million | -610.08 Thousand | 102.44 Thousand | 460.39 Thousand | 606.75 Thousand |
| Other non-cash items | 215.94 Thousand | 366.85 Thousand | 22.11 Million | 361.34 Thousand | 270.5 Thousand | 7.43 Million |
| Investing Cash Flow | 2843.00 | -2323.00 | 452.6 Thousand | 20.1 Thousand | -1651.00 | 7.35 Million |
| Investments in PPE | 2843.00 | -2323.00 | -5252.00 | -3490.00 | -3574.00 | -7595.00 |
| Acquisitions | 2843.00 | - | -457.86 | -23.60 | -1.92 | - |
| Investment purchases | - | - | -345.54 Thousand | -596.52 Thousand | -618.1 Thousand | -493.82 Thousand |
| Sales/Maturities of investments | - | - | 803.4 Thousand | 620.12 Thousand | 620.02 Thousand | 7.85 Million |
| Other Investing Activities | -2843.00 | - | 457.86 | 23.60 | 1.92 | 7362.39 |
| Financing Cash Flow | 13.56 Million | 8.55 Million | 9737.28 | 10.59 Million | 96.5 Thousand | 8.9 Million |
| Debt repayment | -624.3 Thousand | -624.3 Thousand | - | -244.65 Thousand | - | - |
| Dividends payments | - | - | - | - | - | -7.33 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.19 Million | 365.31 Thousand | 9.73 Million | 8.65 Million | 171.21 Thousand | 316.26 Thousand |
| Other Financing Activities | 13.56 Thousand | 8.81 Million | 9737.28 | 2.18 Million | -74.71 Thousand | 15.92 Million |
| Accounts receivables | -305.69 Thousand | -980.82 Thousand | -22.5 Thousand | 698.37 Thousand | -322.66 Thousand | -122.6 Thousand |
| Accounts payables | 1.88 Million | -344.95 Thousand | -544.58 Thousand | -535.55 Thousand | 883.04 Thousand | 729.35 Thousand |
| Inventory | 305.69 Thousand | - | 544.58 Thousand | 535.55 Thousand | -883.04 Thousand | -729.35 Thousand |
| Other working capital | -305.69 Thousand | -119.39 Thousand | -587.58 Thousand | -595.92 Thousand | 783.06 Thousand | 729.35 Thousand |
| Cash at beginning of period | 2.12 Million | 5.58 Million | 6.25 Million | 4.9 Million | 12.36 Million | 1.6 Million |
| Cash at end of period | 9.79 Million | 2.12 Million | 5.58 Million | 6.25 Million | 4.9 Million | 12.36 Million |
| Capital Expenditure | 2843.00 | -2323.00 | -5252.00 | -3490.00 | -3574.00 | -7595.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7.66 Million | -3.46 Million | -666.31 Thousand | 1.34 Million | -7.46 Million | 10.76 Million |
| Free Cash Flow | -5.9 Million | -12.01 Million | -10.86 Million | -9.27 Million | -7.55 Million | -5.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.57 Million | -3.79 Million | -7.71 Million | -3.22 Million | -1.97 Million | -1.1 Million |
| Depreciation & Amortization | 1000.00 | - | 7570.00 | 4670.00 | 969.00 | 1000.00 |
| Deferred income taxes | - | - | -190.85 | -37.01 | -37.01 | -50.28 |
| Stock-based compensation | 22.06 | - | 190.85 | 37.01 | 37.01 | 50.28 |
| Change in working capital | 513.33 Thousand | -1.49 Million | 1.58 Million | 2 Million | -155.4 Thousand | 126.27 Thousand |
| Other non-cash items | 196.8 Thousand | 1.6 Million | 215.94 Thousand | 39.86 Thousand | 45.25 Thousand | 56.1 Thousand |
| Investing Cash Flow | - | - | 2843.00 | -1241.00 | - | 1602.00 |
| Investments in PPE | -1.00 | - | 2843.00 | 1602.00 | - | - |
| Acquisitions | - | - | 2843.00 | -2843.00 | - | 1602.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -2843.00 | - | - | 1.60 |
| Financing Cash Flow | -134.37 Thousand | 7.92 Million | 13.56 Million | -174.46 Thousand | -171.28 Thousand | -99.9 Thousand |
| Debt repayment | -134.37 Thousand | -87.73 Thousand | -624.3 Thousand | -174.46 Thousand | -171.28 Thousand | -168.15 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -14.19 Thousand | - | -214.40 |
| Common Stock Issuance | - | 8.01 Million | 14.19 Million | -14 Million | 228.66 Thousand | 68.25 Thousand |
| Other Financing Activities | -134.37 | -340.64 Thousand | 13.56 Thousand | 14.01 Thousand | -171.28 | 114.49 |
| Accounts receivables | 677.89 Thousand | -18.29 Thousand | -305.69 Thousand | -648.52 Thousand | -96.81 Thousand | 204.84 Thousand |
| Accounts payables | -164.55 Thousand | -1.47 Million | 1.88 Million | 2.65 Million | -58.58 Thousand | -78.57 Thousand |
| Inventory | - | - | 305.69 Thousand | 648.52 Thousand | 58.58 Thousand | 78.57 Thousand |
| Other working capital | 677.89 Thousand | -18.29 Thousand | -305.69 Thousand | -648.52 Thousand | -58.58 Thousand | -78.57 Thousand |
| Cash at beginning of period | 12.54 Million | 9.79 Million | 2.12 Million | 11.14 Million | 13.39 Million | 14.41 Million |
| Cash at end of period | 9.38 Million | 12.54 Million | 9.79 Million | 9.79 Million | 11.14 Million | 13.39 Million |
| Capital Expenditure | -1.00 | - | 2843.00 | 1602.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.16 Million | 2.75 Million | 7.66 Million | -1.34 Million | -2.25 Million | -1.02 Million |
| Free Cash Flow | -3.03 Million | -5.16 Million | -5.9 Million | -1.17 Million | -2.08 Million | -922.96 Thousand |
IIPR
6183
WPDPF
RYA
JSMR
ERES